Aemetis, Inc (AMTX) 10-K Annual Report March 2016

Aemetis, Inc. (NASDAQ: AMTX), an advanced renewable fuels and biochemicals company, today announced its financial results for the fourth quarter and twelve months ended December 31, 2015.

Financial Highlights for 2015

●	Revenues of $147 million in 2015, down from $208 million in 2014

●	Adjusted EBITDA of $(3) million in 2015, down from $30 million in 2014

●	$22 million of EB-5 funding released to the company from escrow during 2015

“In 2015, our financial and operational performance was affected by excess supply in ethanol markets,” said Eric McAfee, Chairman and Chief Executive Officer of Aemetis. “During this past year, Aemetis significantly increased production at our biodiesel and glycerin biorefinery in India, to take advantage of deregulation and the removal of subsidies in the diesel market. The biodiesel domestic market in India continues to grow, with our expanding sales of B100 as a transportation fuel to replace diesel. In 2016, we plan to increase the profitability of our ethanol business by the adoption of patented technologies for the production of cellulosic ethanol and related products at the Keyes plant,” added McAfee.

Today, Aemetis will host an earnings review call at 10:00 am Pacific (PT). For details on the call, visit: http://www.aemetis.com/investors/conference-call/

The following information was filed by Aemetis, Inc (AMTX) on Thursday, March 24, 2016 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

Please wait while we load the requested 10-K report or click the link below:

https://last10k.com/sec-filings/report/738214/000135448816006728/amtx_10k.htm

View differences made from one year to another to evaluate Aemetis, Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Aemetis, Inc.

Continue

Assess how Aemetis, Inc's management team is paid from their Annual Proxy

Aemetis, Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2016 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Material Contracts, Statements, Certifications & more

Aemetis, Inc provided additional information to their SEC Filing as exhibits

Exhibit 1.1: At Market Issuance Sales Agreement

Exhibit 10.68: Limited Waiver And Amendment No. 12

Exhibit 10.69: Letter Of Intent

Exhibit 21: List Of Subsidiaries

Exhibit 23: Consent Of Independent Registered Public Accounting Firm

Exhibit 31.1: Certifications

Exhibit 31.2: Certifications

Exhibit 32.1: Certifications

Exhibit 32.2: Certifications

Ticker: AMTX
CIK: 738214
Form Type: 10-K Annual Report
Accession Number: 0001354488-16-006728
Submitted to the SEC: Mon Mar 28 2016 5:43:18 PM EST
Accepted by the SEC: Tue Mar 29 2016
Period: Thursday, December 31, 2015
Industry: Industrial Organic Chemicals